FINANCIALS

CYCN Cyclerion Therapeutics Inc 1755237

Income Statement
Revenue	cycn-20241231	2,000,000
Net Income	cycn-20241231	-3,057,000
Profit Margin		-152.85%

Balance Sheet
Current Assets	4,225,000
Assets	9,575,000
Current Liabilities	725,000
Liabilities	725,000
Equity	8,850,000
Shares Out	4,330,000

Cash Flow Statement
Operating Cash Flow	-4,333,000

Market Analysis
Market Cap	13,250,757
Price	3.06
BVPS	3.27
PB	0.80
EPS	-1.11
PS	3.68
FCF	-4,333,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view CYCN documents filed with the SEC.

CYCN Filings Clear

View A List of Tickers